CASEY SCHNEIDER: Open Payments
NPI 1780018853 · PACE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 22 payments from 8 companies in 2025. Trend: 2023 $276 · 2024 $289 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $112 |
| Novo Nordisk Inc | 4 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| SHIELD THERAPEUTICS INC | 2 | $38 |
| Verona Pharma, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: Kerendia, AIRSUPRA, Ozempic, XIFAXAN, ACCRUFER, Ohtuvayre, MOUNJARO, FARXIGA.
Industry payments across FL — which companies pay providers there.
